Cellectar Biosciences Inc... (CLRB)
NASDAQ: CLRB
· Real-Time Price · USD
7.98
0.60 (8.13%)
At close: Jun 27, 2025, 3:59 PM
7.23
-9.40%
After-hours: Jun 27, 2025, 05:51 PM EDT
8.13% (1D)
| Bid | 7.05 |
| Market Cap | 367.72M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -24.54M |
| EPS (ttm) | -0.63 |
| PE Ratio (ttm) | -12.67 |
| Forward PE | -14.67 |
| Analyst | Buy |
| Ask | 8.28 |
| Volume | 111,743 |
| Avg. Volume (20D) | 419,334 |
| Open | 7.03 |
| Previous Close | 7.38 |
| Day's Range | 7.03 - 8.20 |
| 52-Week Range | 6.50 - 94.50 |
| Beta | 0.52 |
About CLRB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLRB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLRB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+16.58%
Cellectar Biosciences shares are trading higher af...
Unlock content with
Pro Subscription
3 weeks ago
-11.62%
Cellectar Biosciences shares are trading lower. The company announced it entered into definitive agreements to raise $2.5 million from the sale of shares.
1 month ago · seekingalpha.com
Cellectar Biosciences Inc. (CLRB) Q1 2025 Earnings Call TranscriptCellectar Biosciences Inc. (NASDAQ:CLRB ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Jim Caruso - President and CEO Chad Kolean - CFO Jarrod Longcor - COO Anne Marie...
